{
    "article_link": "https://doi.org/10.1186/s12967-023-04683-6",
    "data": [
        {
            "id": "data_1",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE193337",
            "format": "Fastq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE193337"
        },
        {
            "id": "data_2",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141445",
            "format": "Fastq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE141445"
        },
        {
            "id": "data_3",
            "omics": "Transcriptomics",
            "link": "https://portal.gdc.cancer.gov/",
            "format": "Processed Data",
            "source": "The Cancer Genome Atlas (TCGA)",
            "public_id": "TCGA-PRAD"
        },
        {
            "id": "data_4",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21034",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE21034"
        },
        {
            "id": "data_5",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE70770",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE70770"
        },
        {
            "id": "data_6",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE28680",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE28680"
        },
        {
            "id": "data_7",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6811",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE6811"
        },
        {
            "id": "data_8",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46691",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE46691"
        },
        {
            "id": "data_9",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116918",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE116918"
        },
        {
            "id": "data_10",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE2109",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE2109"
        },
        {
            "id": "data_11",
            "omics": "DNA Methylation",
            "link": "https://portal.gdc.cancer.gov/",
            "format": "Processed Data",
            "source": "The Cancer Genome Atlas (TCGA)",
            "public_id": "TCGA-PRAD"
        },
        {
            "id": "data_12",
            "omics": "Transcriptomics",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62944",
            "format": "txt",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "Alumkal_2020"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Stemness Analysis",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3",
                "data_11"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Unsupervised Hierarchical Clustering",
            "analysis_data": [
                "analysis_1"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Survival Analysis",
            "analysis_data": [
                "data_3",
                "analysis_2"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Drug Sensitivity Prediction (Original Subtypes)",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "TIME Pattern Analysis",
            "analysis_data": [
                "data_3",
                "analysis_2"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Stemness Subtype Predictor Construction",
            "analysis_data": [
                "data_3",
                "data_4",
                "data_5",
                "data_7",
                "data_12"
            ],
            "label": null
        },
        {
            "id": "analysis_7",
            "analysis_name": "Validation of Stemness Subtype Predictor",
            "analysis_data": [
                "analysis_6"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "Pan-Cancer Validation",
            "analysis_data": [
                "analysis_2",
                "analysis_6"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Functional Pathway Analysis (GSVA/GSEA/Ingenuity Pathway Analysis)",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Mutation Profiling and Copy Number Alteration Analysis",
            "analysis_data": [
                "data_3",
                "data_11"
            ],
            "label": {
                "stemness_subtype": [
                    "LS",
                    "MS",
                    "HS"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_2",
            "metrics": "Proportion",
            "value": "10.1%",
            "features": [
                "High Stemness (HS)"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Proportion",
            "value": "47.2%",
            "features": [
                "Low Stemness (LS)"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Proportion",
            "value": "42.7%",
            "features": [
                "Medium Stemness (MS)"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "PFI",
            "value": "0.00015",
            "features": [
                "High Stemness (HS)"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "OS",
            "value": "No significant difference",
            "features": []
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "DFI",
            "value": "No significant difference",
            "features": []
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "DSS",
            "value": "No significant difference",
            "features": []
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "IC50",
            "value": "Lower IC50 for ADT (bicalutamide, abiraterone), taxanes (paclitaxel, docetaxel), and immunotherapy in HS",
            "features": [
                "bicalutamide",
                "abiraterone",
                "paclitaxel",
                "docetaxel",
                "etoposide",
                "gemcitabine",
                "sunitinib",
                "sorafenib",
                "imatinib",
                "cabozantinib",
                "afatinib",
                "erlotinib",
                "olaparib",
                "talazoparib",
                "AZD5438",
                "cisplatin",
                "cetuximab",
                "mitoxantrone",
                "BI-2536",
                "tacedinaline",
                "SB-431542"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Immune Infiltration",
            "value": "Highest in LS, lowest in HS",
            "features": [
                "CD4T",
                "M1 macrophages",
                "M2 macrophages"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Stromal Score",
            "value": "Highest in LS, lowest in HS",
            "features": [
                "LS",
                "MS",
                "HS"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Immune Score",
            "value": "Highest in LS, lowest in HS",
            "features": [
                "LS",
                "MS",
                "HS"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "ESTIMATE Score",
            "value": "Highest in LS, lowest in HS",
            "features": [
                "LS",
                "MS",
                "HS"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Number of Genes",
            "value": "9",
            "features": [
                "CDK1",
                "KIF4A",
                "TPX2",
                "BUB1",
                "TOP2A",
                "SKA3",
                "DLGAP5",
                "NCAPG",
                "HMMR"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "89.8%",
            "features": [
                "Benign vs. Malignant Tumor Classification",
                "TCGA-PRAD"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "88.6%",
            "features": [
                "Response to Androgen Deprivation Therapy (ADT)",
                "GSE6811"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "80.5%",
            "features": [
                "Response to ADT",
                "GSE28680"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "76.5%",
            "features": [
                "Response to ADT",
                "Alumkal_2020"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "78.9%",
            "features": [
                "Prediction of Biochemical Recurrence",
                "prostate_dkfz_2018"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "74%",
            "features": [
                "Prediction of Biochemical Recurrence",
                "GSE70770"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "72.8%",
            "features": [
                "Prediction of Biochemical Recurrence",
                "GSE21034"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "89.4%",
            "features": [
                "Prediction of Metastasis",
                "GSE21034"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "66.3%",
            "features": [
                "Prediction of Metastasis",
                "GSE46691"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "AUC",
            "value": "65.8%",
            "features": [
                "Prediction of Progression"
            ]
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "HR",
            "value": "2.04",
            "features": [
                "Stemness-related Risk Score (SRS)"
            ]
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "Response Rate",
            "value": "Increased progressively across subtypes",
            "features": [
                "ICB therapy",
                "BLCA",
                "BRCA",
                "NSCLC",
                "SKCM",
                "HNSCC"
            ]
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Enriched Pathways",
            "value": "Cell cycle-related pathways in HS, nonspecific pathways in LS",
            "features": [
                "Cell Cycle Checkpoints",
                "Metabolic Pathways",
                "MYC Targets",
                "mTORC1 Signaling",
                "Suppressed activity in HS (via IPA)"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "TMB",
            "value": "Significantly higher in HS",
            "features": [
                "TMB"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "SCNAs",
            "value": "Progressively higher in LS:MS:HS = 16%:38%:72%",
            "features": [
                "TP53",
                "ABCA13",
                "TTN",
                "FAT3",
                "PTEN",
                "CDKN1B",
                "RAD51C",
                "FAM175A",
                "CHD1",
                "RB1",
                "FANCC",
                "SPOPL"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "Mutations",
            "value": "TP53 and ABCA13 co-occur in HS; TTN and FAT3 co-occur in LS; BRCA1 and BRCA2 show no significant difference across subtypes",
            "features": [
                "TP53",
                "ABCA13",
                "TTN",
                "FAT3",
                "BRCA1",
                "BRCA2"
            ]
        }
    ]
}